Memantine nanoemulsion: a new approach to treat Alzheimer’s disease

References

• Anuchapreeda, S., et al., 2012. Preparation of lipid nanoemulsions incorporating curcumin for cancer therapy. Journal of nanotechnology, 2012, 270383.
   Google Scholar
• Aucoin, H., et al., 2013. Release of potassium ion and calcium ion from phosphorylcholine group bearing hydrogels. Polymers, 5 (4), 1241–1257.
   Web of Science ®Google Scholar
• Bshara, H., et al., 2014. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats. Carbohydrate polymers, 99, 297–305.
   PubMed Web of Science ®Google Scholar
• Danysz, W., et al., 2000. Neuroprotective and symptomatological action of memantine relevant for Alzheimer’s disease – a unified glutamatergic hypothesis on the mechanism of action. Neurotoxicity research, 2 (2–3), 85–97.
   PubMed Web of Science ®Google Scholar
• Dhuria, S.V., Hanson, L.R., and Frey, W.H., 2010. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. Journal of pharmaceutical sciences, 99 (4), 1654–1673.
   PubMed Web of Science ®Google Scholar
• Esiri, M.M., et al., 1999. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease. The lancet, 354 (9182), 919–920.
   PubMed Web of Science ®Google Scholar
• Fonseca-Santos, B., Gremião, M.P., and Chorilli, M., 2015. Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease. International journal of nanomedicine, 10, 4981–5003.
   PubMed Web of Science ®Google Scholar
• Gupta, B., Chaurasia, U., and Chakraborty, P., 2014. Design and development of oral transmucosal film for delivery of salbutamol sulphate. Journal of pharmaceutical, chemical and biological sciences, 2 (2), 118–129.
   Google Scholar
• Berg, G. and Rapoport, S.L., 2013. Cognitive defects in early Alzheimer’s-type dementia. Archives of neurology, 43 (9), 882–885.
   Google Scholar
• Illum, L., 2004. Is nose‐to‐brain transport of drugs in man a reality? Journal of pharmacy and pharmacology, 56 (1), 3–17.
   PubMed Web of Science ®Google Scholar
• Kaur, A., et al., 2017. Intravaginal delivery of polyphenon 60 and curcumin nanoemulsion gel. AAPS pharmscitech, 18 (6), 2188–2202.
   PubMed Web of Science ®Google Scholar
• Kedare, S.B. and Singh, R.P., 2011. Genesis and development of DPPH method of antioxidant assay. Journal of food science and technology, 48 (4), 412–422.
   PubMed Web of Science ®Google Scholar
• Kumar, M., et al., 2008. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. International journal of pharmaceutics, 358 (1–2), 285–291.
   PubMed Web of Science ®Google Scholar
• Lagouge, M. and Larsson, N.G., 2013. The role of mitochondrial DNA mutations and free radicals in disease and ageing. Journal of internal medicine, 273 (6), 529–543.
   PubMed Web of Science ®Google Scholar
• Langevin, D., 2000. Influence of interfacial rheology on foam and emulsion properties. Advances in colloid and interface science, 88 (1–2), 209–222.
   PubMed Web of Science ®Google Scholar
• Le Denmat, M., Anton, M., and Beaumal, V., 2000. Characterisation of emulsion properties and of interface composition in O/W emulsions prepared with hen egg yolk, plasma and granules. Food hydrocolloids, 14 (6), 539–549.
   Web of Science ®Google Scholar
• Maragos, W.F., et al., 1987. Glutamate dysfunction in Alzheimer’s disease: an hypothesis. Trends in neurosciences, 10 (2), 65–68.
   Web of Science ®Google Scholar
• McKhann, G., et al., 1984. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS‐ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34 (7), 939–939.
   PubMed Web of Science ®Google Scholar
• Md, S., et al., 2014. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug development and industrial pharmacy, 40 (2), 278–287.
   PubMed Web of Science ®Google Scholar
• Mittal, D., et al., 2014. Insights into direct nose to brain delivery: current status and future perspective. Drug delivery, 21 (2), 75–86.
   PubMed Web of Science ®Google Scholar
• Mobius, H.J., Stoffler, A., and Graham, S.M., 2004. Memantine hydrochloride: pharmacological and clinical profile. Drugs of today, 40 (8), 685–696.
   PubMed Web of Science ®Google Scholar
• Nigam, K., et al., 2019. Baclofen-loaded poly (d, l-lactide-co-glycolic acid) nanoparticles for neuropathic pain management: in vitro and in vivo evaluation. Rejuvenation research, 22 (3), 235–245.
   PubMed Web of Science ®Google Scholar
• Pandey, Y.R., et al., 2016. Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation. Nanotechnology, 27 (2), 025102.
   PubMed Web of Science ®Google Scholar
• Pereira-Lachataignerais, J., et al., 2006. Study and formation of vesicle systems with low polydispersity index by ultrasound method. Chemistry and physics of lipids, 140 (1–2), 88–97.
   PubMed Web of Science ®Google Scholar
• Prieto, E., et al., 2012. Gantrez AN nanoparticles for ocular delivery of memantine: in vitro release evaluation in albino rabbits. Ophthalmic research, 48 (3), 109–117.
   PubMed Web of Science ®Google Scholar
• Sánchez-López, E., et al., 2018. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization. Journal of nanobiotechnology, 16 (1), 32.
   PubMed Web of Science ®Google Scholar
• Sharma, D., et al., 2015. Nose-to-brain delivery of PLGA-diazepam nanoparticles. AAPS pharmscitech, 16 (5), 1108–1121.
   PubMed Web of Science ®Google Scholar
• Sobczak, A., et al., 2013. Determination of adamantane derivatives in pharmaceutical formulations by using spectrophotometric UV-Vis method. Drug development and industrial pharmacy, 39 (5), 657–661.
   PubMed Web of Science ®Google Scholar
• Sun, X., Jin, L., and Ling, P., 2012. Review of drugs for Alzheimer’s disease. Drug discovries and therapeutics, 6 (6), 285–290.
   PubMedGoogle Scholar
• Szőllősi, R. and Varga, I.S.I., 2002. Total antioxidant power in some species of Labiatae: adaptation of FRAP method. Acta biologica (szeged), 46 (3–4), 125–127.
   Google Scholar
• Vyas, T.K., et al., 2005. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting. Journal of drug targeting, 13 (5), 317–324.
   PubMed Web of Science ®Google Scholar
• Witt, A., Macdonald, N., and Kirkpatrick, P., 2004. Memantine hydrochloride. Nature reviews drug discovery, 3 (2), 109–110.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., et al., 2004. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. International journal of pharmceutics, 275 (1–2), 85–96.
   PubMed Web of Science ®Google Scholar